PROSTAGLADIN ANALOGUES BY THE ORAL OR VAGINAL ROUTE FOR THE ROUTINE MANAGEMENT OF THE THIRD STAGE OF LABOUR

发明公开

EP0784475A1 PROSTAGLADIN ANALOGUES BY THE ORAL OR VAGINAL ROUTE FOR THE ROUTINE MANAGEMENT OF THE THIRD STAGE OF LABOUR 失效

标题翻译：前列腺素口服或阴道给药劳动出生第三阶段的常规治疗

请登陆查看更多内容

专利标题： PROSTAGLADIN ANALOGUES BY THE ORAL OR VAGINAL ROUTE FOR THE ROUTINE MANAGEMENT OF THE THIRD STAGE OF LABOUR
专利标题（中）： 前列腺素口服或阴道给药劳动出生第三阶段的常规治疗
申请号： EP95932120.0

申请日： 1995-09-26
公开(公告)号： EP0784475A1

公开(公告)日： 1997-07-23
发明人: EL-REFAEY, Hazem 62A Prince of Wales Mansions
申请人： UNIVERSITY COLLEGE LONDON
申请人地址： 5 Gower Street London WC1E 6BT GB
专利权人： UNIVERSITY COLLEGE LONDON
当前专利权人： UNIVERSITY COLLEGE LONDON
当前专利权人地址： 5 Gower Street London WC1E 6BT GB
代理机构： Stebbing, Peter John Hunter, et al
优先权： GB19940019566 19940927
国际公布： WO1996009825 19960404
主分类号： A61K31
IPC分类号： A61K31

PROSTAGLADIN ANALOGUES BY THE ORAL OR VAGINAL ROUTE FOR THE ROUTINE MANAGEMENT OF THE THIRD STAGE OF LABOUR

摘要：

The invention relates to the utilisation of a prostagladin analogue by the oral or vaginal route for the routine management of the third stage of labour. The invention shows that the use of a prostagladin, particularly Misoprostol gives excellent results in the prevention of postpartum haemorrhage (PPH) when routinely administered immediately postpartum at 400-600 νg.

信息查询

Global Dossier Espacenet